Shabir Ahmad Mir (Shabir A Mir)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Molecular Docking

Chronic Lymphocytic Leukemia

Tyrosine Kinase

Top Venues

Molecules (Basel, Switzerland)

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz, Ayoub Al Othaim, Wael Alturaiki, Sami G Almalki, Abdulrahman Algarni, Suliman Abdallah Alsagaby
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation. Molecules (Basel, Switzerland) 28 (8) (2023)
Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz, Ayoub Al Othaim, Wael Alturaiki, Sami G Almalki, Abdulrahman Algarni, Suliman Abdallah Alsagaby
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation. Molecules (Basel, Switzerland) 28 (8) (2023)
Abdulaziz Yahya Sharahili, Shabir Ahmad Mir, Sahar ALDosari, Md Dilshad Manzar, Bader Mohammed Alshehri, Ayoub Al Othaim, Fayez Alghofaili, Yahya Madkhali, Kamal Shaker Albenasy, Jazi Shaydied Alotaibi
Correlation of HbA1c Level with Lipid Profile in Type 2 Diabetes Mellitus Patients Visiting a Primary Healthcare Center in Jeddah City, Saudi Arabia: A Retrospective Cross-Sectional Study. Diseases (Basel, Switzerland) 11 (4) (2023)
Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz, Ayoub Al Othaim, Wael Alturaiki, Sami G Almalki, Abdulrahman Algarni, Suliman Abdallah Alsagaby
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation. Molecules (Basel, Switzerland) 28 (8) (2023)
Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz, Ayoub Al Othaim, Wael Alturaiki, Sami G Almalki, Abdulrahman Algarni, Suliman Abdallah Alsagaby
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation. Molecules (Basel, Switzerland) 28 (8) (2023)
Shabir Ahmad Mir, Mohammed A Alaidarous, Bader Mohammed Alshehri, Abdul Aziz Bin Dukhyil, Saeed S Banawas, Yahya Madkhali, Suliman Abdallah Alsagaby, Ayoub Al Othaim
Immunoinformatics-Based Identification of B and T Cell Epitopes in RNA-Dependent RNA Polymerase of SARS-CoV-2. Vaccines 10 (10) (2022)
Sadaf Jahan, Shouvik Mukherjee, Shaheen Ali, Urvashi Bhardwaj, Ranjay Kumar Choudhary, Santhanaraj Balakrishnan, Asma Naseem, Shabir Ahmad Mir, Saeed S Banawas, Mohammed A Alaidarous, Hadeel Alyenbaawi, Danish Iqbal, Arif Jamal Siddiqui
Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects. Cells 11 (3) (2022)
Sadaf Jahan, Neeru Singh Redhu, Arif Jamal Siddiqui, Danish Iqbal, Johra Khan, Saeed S Banawas, Mohammed A Alaidarous, Bader Mohammed Alshehri, Shabir Ahmad Mir, Mohd Adnan, Aditya Bhushan Pant
Nobiletin as a Neuroprotectant against NMDA Receptors: An In Silico Approach. Pharmaceutics 14 (6) (2022)
Saeed Mohammed Alqahtani, Suliman Abdallah Alsagaby, Shabir Ahmad Mir, Mohammed A Alaidarous, Abdulaziz Bin Dukhyil, Bader Alshehri, Saeed S Banawas, Wael Alturaiki, Naif Khalaf Al Harbi, Taif Anwar Azad, Waleed Al Abdulmonem
Seroprevalence of Viral Hepatitis B and C among Blood Donors in the Northern Region of Riyadh Province, Saudi Arabia. Healthcare (Basel, Switzerland) 9 (8) (2021)
Shabir Ahmad Mir, Bader M Alshehri, Mohammed Alaidarous, Saeed S Banawas, Abdul Aziz A Bin Dukhyil, Mohammad K Alturki
Prevalence of Hemoglobinopathies (β-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia. Hemoglobin 44 (1) (2020)